NCT00549289
Completed
Phase 3
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
ConditionsDry Eye Syndromes
Drugscyclosporine A
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Dry Eye Syndromes
- Sponsor
- Sirion Therapeutics, Inc.
- Locations
- 1
- Status
- Completed
- Last Updated
- 18 years ago
Overview
Brief Summary
The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of dry eye syndrome
Exclusion Criteria
- •Intraocular or refractive surgery in the study eye within 3 months prior to study start
- •Unwilling to discontinue use of contact lenses during the study
- •Pregnancy or lactation
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)Dry Eye SyndromesNCT00548301Sirion Therapeutics, Inc.
Completed
Phase 3
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)Dry Eye SyndromesNCT00502073Sirion Therapeutics, Inc.
Unknown
Phase 4
Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency VirusDry Eye SyndromesHIV SeropositivityNCT00797030Universidade Federal do Rio de Janeiro20
Completed
Phase 2
Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsKeratoconjunctivitis SiccaSjogren's SyndromeNCT00001731National Eye Institute (NEI)30
Completed
Not Applicable
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens WearersContact Lens Wearers With Dry Eye SyndromeNCT00335114University of Alabama at Birmingham40